EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Early infliximab levels and clearance predict outcomes in acute severe ulcerative colitis

Mohammad Al Hayek, Muhammed Elhadi iD

Translational Gastroenterology and Hepatology · 2026-07 · 11 · 82-82

DOI: 10.21037/tgh-2026-0037 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-07. Verfasst von Mohammad Al Hayek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

. In patients with moderate-to-severe UC, higher trough infliximab concentrations have been linked to better remission rates (9). However, the role of early infliximab pharmacokinetics in ASUC remains unclear. The association between early infliximab exposure and clinical outcomes in patients with steroid-refractory ASUC was investigated in a recent post hoc analysis of the PREDICT-UC trial (10). The study demonstrated that lower serum infliximab levels on day 3 ( ≤ 57.9 μg/mL) predicted treatment failure by day 14 and colectomy within 3 months. In addition, increased infliximab clearance by day 7 was associated with early non-response, subsequent treatment failure, and a higher risk of colectomy. Higher fecal infliximab concentrations on day 3 were also associated with greater endoscopic disease severity and predicted non-response at day 7. Importantly, the study suggests that increased infliximab clearance, previously associated with poor outcomes, may be overcome by

Schlagwörter

Stichwörter der Autor:innen

Acute severe ulcerative colitis (ASUC)colectomydrug clearanceinfliximabtherapeutic drug monitoring (TDM)

Autor:innen und Institutionen

  • Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
  • College of Medicine, Korea University, Seoul, South Korea.

ORCID-Profile: Muhammed Elhadi

Zitieren

APA

Al Hayek, M., & Elhadi, M. (2026). Early infliximab levels and clearance predict outcomes in acute severe ulcerative colitis. Translational Gastroenterology and Hepatology, 11, 82-82. https://doi.org/10.21037/tgh-2026-0037

Vancouver

Al Hayek M, Elhadi M. Early infliximab levels and clearance predict outcomes in acute severe ulcerative colitis. Translational Gastroenterology and Hepatology. 2026;11:82-82. doi:10.21037/tgh-2026-0037

BibTeX
@article{AlHayek2026,
  author = {Al Hayek, Mohammad and Elhadi, Muhammed},
  title = {Early infliximab levels and clearance predict outcomes in acute severe ulcerative colitis},
  journal = {Translational Gastroenterology and Hepatology},
  year = {2026},
  volume = {11},
  pages = {82--82},
  doi = {10.21037/tgh-2026-0037}
}
Kostenlos starten →